Leptin promotes aggregation of human platelets via the long form of its receptor

Plasma leptin levels are elevated in most obese individuals, and obesity is accompanied by a high incidence of cardiovascular disease. Therefore, leptin could be involved in the pathogenesis of cardiovascular disease. In the present study, the role of leptin was explored in the regulation of platelet function. The expression of the long form of the leptin receptor was detected in human platelets. At 50 ng/ml, human leptin induced phosphorylation of several proteins of platelets at the tyrosine residue. Neither leptin at concentrations less than or equal to 100 ng/ml nor ADP at concentrations greater than or equal to 1 mu mol/l affected platelet aggregation, However after pretreatment with 100 ng/ml leptin for 5 min, 1 mu mol/l ADP caused aggregation. Thus, leptin and ADP acted synergistically. At a concentration of 2 mu mol/l, ADP induced platelet aggregation, which. was markedly enhanced by 30-100 ng/ml leptin in a concentration-dependent manner. This concentration range corresponds to that of plasma leptin levels in obese individuals. At the lower concentrations (<10 ng/ml) that are observed in normal individuals, leptin had no effect on platelet aggregation. In conclusion, leptin at high concentrations has the novel function of promoting platelet aggregation, which may be a key coupling factor between obesity and the cardiovascular disease associated with syndrome X and diabetes.